Cargando…
Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.
The hypoxic cell radiosensitizer, Ro 07-0582, has now been given in multiple doses to 16 patients. They have received a total of 15-51 g in 3-20 doses. Immediate tolerance was good, and satisfactory plasma levels of the drug were consistently obtained. Neurotoxicity was, however, troublesome: convul...
Autores principales: | Dische, S., Saunders, M. I., Lee, M. E., Adams, G. E., Flockhart, I. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1977
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025511/ https://www.ncbi.nlm.nih.gov/pubmed/861146 |
Ejemplares similares
-
Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results.
por: Foster, J. L., et al.
Publicado: (1975) -
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
por: Pedersen, J. E., et al.
Publicado: (1979) -
Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.
por: Stratford, I. J., et al.
Publicado: (1977) -
Effect of hyperthermia on cytotoxicity of the radiosensitizer Ro-07-0582 in a solid mouse tumour.
por: George, K. C., et al.
Publicado: (1977) -
Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.
por: Hall, E. J., et al.
Publicado: (1977)